✦ LIBER ✦
101 STRIDE: phase III study of therapeutic cancer vaccine L-BLP25 with hormonal treatment as first-line therapy for women with hormone receptor-positive, inoperable, locally advanced, recurrent, or metastatic breast cancer
✍ Scribed by W. Eiermann; D. Miles; T. Gilewski; M. Trudeau; B. Xu; C. Barrios; K. Pendergrass; S.P. Eggleton; O. Kashala; L. Shulman
- Book ID
- 119601118
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 66 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.